Page last updated: 2024-08-16

technetium tc 99m sestamibi and laniquidar

technetium tc 99m sestamibi has been researched along with laniquidar in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bates, SF; Chen, C; Figg, WD; Fojo, T; Kang, M; Robey, R	1
Authier, N; Balayssac, D; Cayre, A; Coudoré, F; Eschalier, A; Ling, B; Maublant, J; Penault-Llorca, F	1

Reviews

1 review(s) available for technetium tc 99m sestamibi and laniquidar

Article	Year
Reversal of multidrug resistance: lessons from clinical oncology. Novartis Foundation symposium, 2002, Volume: 243 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Clinical Trials as Topic; Cyclosporins; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Mice; Mice, Knockout; Neoplasm Proteins; Neoplasms; Piperidines; Pyridines; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Rhodamines; Technetium Tc 99m Sestamibi; Tissue Distribution; Tumor Cells, Cultured	2002

Article

Year

Reversal of multidrug resistance: lessons from clinical oncology.

Novartis Foundation symposium, 2002, Volume: 243

Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Clinical Trials as Topic; Cyclosporins; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Mice; Mice, Knockout; Neoplasm Proteins; Neoplasms; Piperidines; Pyridines; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Rhodamines; Technetium Tc 99m Sestamibi; Tissue Distribution; Tumor Cells, Cultured

2002

Other Studies

1 other study(ies) available for technetium tc 99m sestamibi and laniquidar

Article	Year
Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy. Neuroscience letters, 2009, Nov-06, Volume: 465, Issue:1 Topics: Analgesics, Opioid; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Brain; Cisplatin; Drug Synergism; Ganglia, Spinal; Male; Morphine; Pain; Pain Measurement; Pressure; Quinolines; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord; Technetium Tc 99m Sestamibi	2009

Article

Year

Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy.

Neuroscience letters, 2009, Nov-06, Volume: 465, Issue:1

Topics: Analgesics, Opioid; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Brain; Cisplatin; Drug Synergism; Ganglia, Spinal; Male; Morphine; Pain; Pain Measurement; Pressure; Quinolines; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord; Technetium Tc 99m Sestamibi

2009